Entropy Neurodynamics Limited (ASX:ENP)
Australia
· Delayed Price · Currency is AUD 0.0330
0.00 (0.00%)
At close: Mar 6, 2026
Entropy Neurodynamics Revenue
Entropy Neurodynamics had revenue of 1.58M AUD in the twelve months ending December 31, 2025. In the fiscal year ending June 30, 2025, Entropy Neurodynamics had annual revenue of 1.58M with 19.17% growth.
Revenue
1.58M
Revenue Growth
+19.17%
P/S Ratio
33.70
Revenue / Employee
n/a
Employees
n/a
Market Cap
53.31M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Proteomics International Laboratories | 3.21M |
| EZZ Life Science Holdings | 61.40M |
| Amplia Therapeutics | 5.01M |
| Neurizon Therapeutics | 5.98M |
| Prescient Therapeutics | 4.27M |
| Avecho Biotechnology | 1.24M |
| Radiopharm Theranostics | 16.28M |
| Imugene | 3.94M |